I

Instituto Medico Platense | Clinical Research Department

Research site

(Unclaimed)

Location

Avenida 51 No 315, La Plata, Buenos Aires, Argentina

Site insights

Top conditions

Top treatments

Pimodivir

Ustekinumab

Ribavirin

Proxinium

INM005

Farletuzumab

Taxane

Baloxavir Marboxil

Oseltamivir

Guselkumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 19 total trials

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (RSVHR)

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult sub...

Enrolling

RSV Infection

Drug: EDP-938

Drug: Placebo

A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)

The purpose of this study is to evaluate the pharmacokinetics (PK), efficacy, safety and immunogenicity of ustekinumab and guselkumab in active juven...

Enrolling

Arthritis, Juvenile

Drug: Guselkumab

Drug: Ustekinumab

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Primary objective:- To evaluate the efficacy of oral reparixin versus standard care alone in limiting disease progression in adult patients hospitali...

Enrolling

Infectious Pneumonia

Severe COVID-19

Other: Placebo

Drug: Reparixin